Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
CheelcareTSXV:CHER +3.59%11 PB Ratio is 108.13 as of Jul. 22, 2026, which is 227% above its 10-year median of 33.08. GuruFocus rates TSXV:CHER with a GF Score™ of 11/100. The stock has 3 warning signs investors should review. Among 786 Medical Devices & Instruments companies, Cheelcare ranks worse than 99.36% on this metric.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-07-22), Cheelcare's share price is C$1.73. Cheelcare's Book Value per Share for the quarter that ended in Jan. 2026 was C$0.02. Hence, Cheelcare's PB Ratio of today is 108.13.
The historical rank and industry rank for Cheelcare's PB Ratio or its related term are showing as below:
TSXV:CHER'
s PB Ratio Range Over the Past 10 Years
Min: 13.28 Med: 33.08 Max: 120
Current: 108.13
During the past 2 years, Cheelcare's highest PB Ratio was 120.00. The lowest was 13.28. And the median was 33.08.
TSXV:CHER's PB Ratio is ranked worse than 99.36% of 786
companies
in the Medical Devices & Instruments industry
Industry Median: 2.005
vs TSXV:CHER: 108.13
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Cheelcare PB Ratio Related Terms
Cheelcare PB Ratio Historical Data
* Premium members only.
The historical data trend for Cheelcare's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Cheelcare's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cheelcare PB Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Cheelcare's PB Ratio distribution charts can be found below:
* The bar in red indicates where Cheelcare's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
Cheelcare's PB Ratio for today is calculated as follows:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Cheelcare (TSXV:CHER) has a PB Ratio of 108.13 as of Jul. 22, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Cheelcare and its competitors. This is 227% above median its historical median of 33.08. Over the past decade, Cheelcare's PB Ratio has ranged from 13.28 to 120.00. According to the industry distribution chart, Cheelcare ranks #781 out of 786 companies in the Medical Devices & Instruments industry, placing it in the top 99.4%.
Is Cheelcare's PB Ratio too high?
Cheelcare's current PB Ratio of 108.13 is 227% above median its 10-year median of 33.08. Over the past 10 years, this metric has ranged from a low of 13.28 to a high of 120.00. The Medical Devices & Instruments industry median PB Ratio is 2.01. Cheelcare's value of 108.13 is 5293% above this industry median. Based on the distribution chart, Cheelcare ranks #781 out of 786 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Cheelcare has a GF Score™ of 11/100, reflecting its overall financial health beyond just this single metric.
How does Cheelcare's PB Ratio compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Cheelcare ranks #781 out of 786 companies for PB Ratio. This places Cheelcare in the lower half of its industry. The industry median PB Ratio is 2.01. Cheelcare's value of 108.13 is 5293% above this benchmark. Historically, Cheelcare's own PB Ratio has ranged from 13.28 to 120.00 over the past decade. While the company's 10-year median is 33.08 vs. the industry median of 2.01, Cheelcare has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Medical Devices & Instruments company?
The median PB Ratio among Medical Devices & Instruments companies is 2.01, based on 786 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Cheelcare's current PB Ratio of 108.13 is 5293% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Cheelcare and its competitors. For the Medical Devices & Instruments industry, the median PB Ratio is 2.01 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cheelcare's current PB Ratio is 108.13, which is 227% above median its own 10-year median of 33.08. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cheelcare stock overvalued right now?
Cheelcare (TSXV:CHER) has a current PB Ratio of 108.13. The current PB Ratio is 108.13, which is 227% above median its 10-year median of 33.08 and 5293% above the Medical Devices & Instruments industry median of 2.01. Cheelcare's overall GF Score™ is 11/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Cheelcare (TSXV:CHER), the current PB Ratio is 108.13 as of Jul. 22, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Cheelcare Inc is a company that designs and manufactures inventive mobility devices using robotics. Its product portfolio consists of three key lines: Robotic Complex Rehab Power Wheelchair such devices feature patented self-leveling technology and the lowest seat-to-floor height in their class, enhancing stability and accessibility. Power Add-ons for Manual Wheelchairs designed to convert manual wheelchairs into powered mobility devices, offering users increased independence. Aftermarket Wheelchair Accessories includes a range of OEM equipment, backup cameras, phone chargers, and wheel suspension systems, that allow wheelchair users the ability to supplement their existing equipment to improve safety and convenience.
11GF Score
Get the complete analysis for TSXV:CHER
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSXV:CHER has been successfully added to your 
